Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy.
Judith N TorimiroAubin NanfackWilliam TakangClaude Kalla KeouAwum Nchenda JoyceKevin NjefiKimbong AgyingiIrenee DomkamDesire TakouSylvie MoudourouSamuel SossoRobinson E MbuPublished in: BMC pregnancy and childbirth (2018)
The rates of HBV and HIV-1 infections point to the need for early diagnosis of these viruses during pregnancy and referral to care services in order to minimize the risk of MTCT. Furthermore, our results would be useful for evaluating the HIV PMTCT Programme and Treatment Guidelines for Cameroon.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- hiv aids
- hepatitis c virus
- hiv infected patients
- hiv testing
- men who have sex with men
- healthcare
- hepatitis b virus
- primary care
- south africa
- clinical trial
- palliative care
- liver failure
- mental health
- polycystic ovary syndrome
- adipose tissue
- pregnant women
- study protocol
- quality improvement
- pain management
- chronic pain
- health insurance
- affordable care act